AAKIQASFRGHMARKK

CAS146554-17-8

AAKIQASFRGHMARKK (CAS 146554-17-8, C78H134N28O19S) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of AAKIQASFRGHMARKK
C78H134N28O19S · 1800.1 g/mol
CAS No.
146554-17-8
Formula
C78H134N28O19S
Mol. weight
1800.1 g/mol

Chemical Specifications

Identifiers

CAS number 146554-17-8
Product name AAKIQASFRGHMARKK
Synonyms RC3; PROTEIN KINASE SELECTIDE; PROTEIN KINASE C SELECTIDE(TM) SUBSTRATE; NEUROGRANIN (28-43); NEUROGRANIN FRAGMENT 28-43; NEUROGRANIN 28-43 [AAKIQASFRGHMARKK]; ALA-ALA-LYS-ILE-GLN-ALA-SER-PHE-ARG-GLY-HIS-MET-ALA-ARG-LYS-LYS; AAKIQASFRGHMARKK
Molecular formula C78H134N28O19S
Molecular weight 1800.1 g/mol

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Safety and transport

Safety Statements WGK Germany 3

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of AAKIQASFRGHMARKK?

The CAS Registry Number of AAKIQASFRGHMARKK is 146554-17-8. AAKIQASFRGHMARKK is also known as RC3; PROTEIN KINASE SELECTIDE; PROTEIN KINASE C SELECTIDE(TM) SUBSTRATE.

What is the molecular formula and molecular weight of AAKIQASFRGHMARKK?

The molecular formula of AAKIQASFRGHMARKK is C78H134N28O19S, and its molecular weight is 1800.1 g/mol.

How can I request a quotation for AAKIQASFRGHMARKK?

Send an inquiry for AAKIQASFRGHMARKK (CAS 146554-17-8) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for AAKIQASFRGHMARKK

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.